nitroblue tetrazolium has been researched along with edelfosine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Reed, CB; Tang, W; Ziboh, VA | 1 |
| Albright, CD; Craciunescu, CN; Salganik, RI; Vrablic, AS; Zeisel, SH | 1 |
2 other study(ies) available for nitroblue tetrazolium and edelfosine
| Article | Year |
|---|---|
Antineoplastic ether-linked phospholipid induces differentiation of acute myelogenous leukemic KG-1 cells into macrophage-like cells.
Topics: Antineoplastic Agents; Cell Differentiation; Cell Division; Dose-Response Relationship, Drug; Esterases; Humans; Leukemia, Myeloid, Acute; Macrophages; Nitroblue Tetrazolium; Phospholipid Ethers; Tumor Cells, Cultured | 1991 |
Altered mitochondrial function and overgeneration of reactive oxygen species precede the induction of apoptosis by 1-O-octadecyl-2-methyl-rac-glycero-3-phosphocholine in p53-defective hepatocytes.
Topics: Animals; Antigens, Polyomavirus Transforming; Antioxidants; Apoptosis; Cell Line, Transformed; Electrophoresis, Agar Gel; Hepatocytes; Intracellular Membranes; Male; Membrane Potentials; Mitochondria, Liver; Nitroblue Tetrazolium; Phosphatidylcholines; Phospholipid Ethers; Rats; Rats, Inbred F344; Reactive Oxygen Species; Tumor Suppressor Protein p53; Vitamin E | 2001 |